← Evidence map

ArticleFrontiers in pharmacology2020

Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease.

Daniel P Zimmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32322204